Teiko bio(@TeikoBio) 's Twitter Profile Photo

Exciting keynote by Dr. Dr Marcela Maus of MGH on & . Loss of IFNyR signaling in solid tumors can drive resistance and CAR-T cytotoxicity suggesting a “crucial role of IFNyR in stabilizing and enhancing solid tumor CAR T cell interactions.”

Exciting #IO360nyc keynote by Dr. @MarcelaMaus of MGH on #solidtumors & #CART. Loss of IFNyR signaling in solid tumors can drive resistance and CAR-T cytotoxicity suggesting a “crucial role of IFNyR in stabilizing and enhancing solid tumor CAR T cell interactions.”#CancerResearch
account_circle
Affini-T Therapeutics(@affinit_tx) 's Twitter Profile Photo

Tuning in to the 23rd Annual Needham & Company Healthcare Conference? Connect virtually with our CFO, Kathy Bergsteinsson, to learn more about our work targeting mutations in .

Tuning in to the 23rd Annual Needham & Company Healthcare Conference? Connect virtually with our CFO, Kathy Bergsteinsson, to learn more about our work targeting #oncogenicdriver mutations in #solidtumors.
account_circle
Matthew Hassan(@HassanClan) 's Twitter Profile Photo

Remember $Nwbo ( ) is going to be a in not just for (soon), but in time for ALL especially in combination with treatments.
Being autologous, it is , , !

youtu.be/cU_-1ECBMAU

account_circle
Ahmad Tarhini(@ATarhiniMDPhD) 's Twitter Profile Photo

Society for Immunotherapy of Cancer⁩ │ Abstract 151 heterogeneity between paired primary & metastatic & implications for -based personalized cancer │ Oncology Research Information Exchange Network (ORIEN) Team Science ⁦Moffitt Cancer Center

#SITC23 ⁦@sitcancer⁩ │ Abstract 151 #Genetic heterogeneity between paired primary & metastatic #solidtumors & implications for #neoantigen -based personalized cancer #vaccines │ Oncology Research Information Exchange Network (ORIEN) Team Science ⁦@MoffittNews⁩
account_circle
Seattle Children's Therapeutics (SCTx)(@SCTherapeutics) 's Twitter Profile Photo

Our patients travel from across the United States and countries around the world to participate in our CAR T-cell clinical trials. Learn more about our clinical trials for , and . tinyurl.com/4cttxh7d

Our patients travel from across the United States and countries around the world to participate in our CAR T-cell #immunotherapy clinical trials.  Learn more about our clinical trials for #leukemia, #lymphoma #CNStumors and #solidtumors. tinyurl.com/4cttxh7d
account_circle
SoniaGuedan(@GuedanS) 's Twitter Profile Photo

Come today to see our poster 1242 at ⁦ASGCT⁩ , 'Dissecting the Mechanisms of CAR-T Cell Dysfunction in a Mouse Model of Solid Tumors', presented by the super talented PhD student Paula Barbao. It's a bit hidden, but you can’t miss it!

Come today to see our poster 1242 at ⁦@ASGCTherapy⁩ , 'Dissecting the Mechanisms of CAR-T Cell Dysfunction in a Mouse Model of Solid Tumors', presented by the super talented PhD student Paula Barbao. It's a bit hidden, but you can’t miss it! #asgct2023 #cart #solidtumors
account_circle
Triumvira Immunologics(@Triumvirainc) 's Twitter Profile Photo

Our TAC-T technology contains an intracellular co-receptor domain that binds directly to native receptors, steering the body’s natural immune response to attack .

Learn more: bit.ly/48mZX7O

Our TAC-T technology contains an intracellular co-receptor domain that binds directly to native #Tcell receptors, steering the body’s natural immune response to attack #solidtumors.

Learn more: bit.ly/48mZX7O
account_circle
Calyx(@calyxai) 's Twitter Profile Photo

Proud to have supported Iovance on this approval – the first tumor-infiltrating lymphocyte ( ) therapy for – and excited about its impact on patients & the research community. calyx.ai/s/9n18

account_circle
Molecular Oncology(@MolOncology) 's Twitter Profile Photo

🐇Our April issue is out🥚

🔓buff.ly/3TXlLBg

💠Cover: Improved subgroup identification for pan-cancer via rank-based Bayesian clustering

🔭Explore Articles on , Commentaries & Viewpoint on

🐇Our April issue is out🥚

🔓buff.ly/3TXlLBg

💠Cover: Improved subgroup identification for pan-cancer via rank-based Bayesian clustering

🔭Explore Articles on #Neuroendocrine #SolidTumors #CerebralOrganoids, Commentaries #CancerMetabolism & Viewpoint on #Mitochondria
account_circle
Seattle Children's Therapeutics (SCTx)(@SCTherapeutics) 's Twitter Profile Photo

We enrolled our 1st patient in our 1st immunotherapy clinical trial for
Seattle Children's's in 2013. Today we offer trials for / , and & we're on the verge of enrolling our 500th patient. bit.ly/3ZQAbVb

account_circle
Elevation Oncology(@elevationonc) 's Twitter Profile Photo

May is !

Join us in celebrating the scientists whose dedication to research saves millions of lives. Visit our website to discover how we contribute to the cause.

elevationoncology.com

account_circle
POEM Group(@poem_group) 's Twitter Profile Photo

Additional talks and a panel discussion during session 2 of POEM Virtual symposium highlighting the role and importance of genomic testing in Pediatric solid tumors.

Additional talks and a panel discussion during session 2  of POEM Virtual symposium highlighting the role and importance of genomic testing in Pediatric solid tumors. 
 #solidtumors #pediatriccancer #Genomics #POEM
account_circle
TScan Therapeutics(@TScan_Tx) 's Twitter Profile Photo

Today we announced FDA clearance of our third IND under T-Plex! TSC-200-A0201 is an HLA-A*02:01-specific -T targeting HPV16. This milestone supports our mission to grow the ImmunoBank and the reach of multiplexed therapy for . bit.ly/3J0ejRo

Today we announced FDA clearance of our third IND under T-Plex! TSC-200-A0201 is an HLA-A*02:01-specific #TCR-T targeting HPV16. This milestone supports our mission to grow the ImmunoBank and the reach of multiplexed therapy for #SolidTumors. bit.ly/3J0ejRo
account_circle